Factors Associated With Liver Steatosis in People With Human Immunodeficiency Virus on Contemporary Antiretroviral Therapy.
Carlotta RiebensahmAnnalisa BerzigottiBernard SurialHuldrych F GünthardPhilip E TarrHansjakob FurrerAndri RauchGilles Wandelernull nullPublished in: Open forum infectious diseases (2022)
Our findings suggest a high prevalence of liver steatosis among people with HIV (PWH) on ART in Switzerland. In addition to established risk factors, the use of tenofovir alafenamide was associated with hepatic steatosis.